← Back to all trials
Completed
NCT07944209
Remimazolam Induction Methods in Robotic Cholecystectomy
Conditions: General Anesthesia, Cholecystectomy
Sex: All
Ages: 20 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 90
Sponsor: Korea University Guro Hospital
Location: Korea University Ansan Hospital Ansan Gyeonggi-do
Summary
This prospective randomized study compares two methods of remimazolam induction in adults aged 20 to 70 years scheduled for elective single-port robotic cholecystectomy: a single intravenous bolus of 0.2 mg/kg versus continuous intravenous infusion at 12 mg/kg/hour. The primary outcome is emergence time, from discontinuation of sevoflurane to recovery of consciousness defined as a Modified Observer's Assessment of Alertness/Sedation (MOAA/S) score of 5. Ninety participants were enrolled.
Eligibility Criteria
Inclusion Criteria:
* Age 20 to 70 years
* Scheduled for elective single-port robotic cholecystectomy
Exclusion Criteria:
* Known hypersensitivity to benzodiazepines or flumazenil
* Substance use disorder
* Preoperative total bilirubin greater than 3.0 mg/dL
* Liver transaminase levels greater than twice the upper limit of normal within one week before surgery
Source: ClinicalTrials.gov (NCT07944209). StuddyBuddy aggregates publicly available trial information.